Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

Bipolar Disorder

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Distinct cognitive changes in male patients with obstructive sleep apnoea without co-morbidities.

Frontiers in sleep·2024

Same author

Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2024

Same author

Ketamine cystitis following ketamine therapy for treatment-resistant depression - case report.

BMC psychiatry·2024

Same author

Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights.

Neuropsychiatric disease and treatment·2023

Same author

Limited clinical validity of univariate resting-state EEG markers for classifying seizure disorders.

Brain communications·2023

Same author

The effect of a low-calorie diet on depressive symptoms in individuals with overweight or obesity: a systematic review and meta-analysis of interventional studies.

Psychological medicine·2023

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Lithium in mood disorders: increasing evidence base, declining use?

Allan H Young¹, Judith M Hammond

¹Institute of Mental Health, University of British Columbia, University Boulevard, Vancouver, British Columbia, Canada V6T 1Z3. allan.young@ubc.ca

The British Journal of Psychiatry : the Journal of Mental Science

|December 7, 2007

Summary

Lithium treatment for bipolar disorder is effective and reduces suicide risk, despite declining use. Psychiatrists should continue prescribing lithium for its proven benefits in managing this condition.

Related Experiment Videos

Last Updated: Jul 9, 2026

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

Psychiatry
Pharmacology
Mental Health

Background:

Lithium is a well-established mood stabilizer for bipolar disorder.
Despite increased knowledge of its efficacy and side-effects, lithium use may be decreasing.
Concerns about side-effects or other factors might be contributing to reduced prescription rates.

Purpose of the Study:

To review the current evidence on lithium's efficacy in bipolar disorder.
To address the potential decline in lithium utilization.
To reinforce the importance of lithium maintenance therapy.

Main Methods:

Review of recent meta-analyses on lithium treatment for bipolar disorder.
Analysis of data regarding lithium's impact on suicide and suicidality.
Synthesis of current clinical knowledge on lithium's benefits and risks.

Main Results:

Recent meta-analyses confirm the significant benefits of maintenance lithium treatment.
Lithium therapy demonstrably reduces suicide rates and suicidal ideation in patients with bipolar disorder.
The evidence strongly supports lithium's role in preventing relapse and improving long-term outcomes.

Conclusions:

Maintenance lithium treatment remains a highly efficacious therapy for bipolar disorder.
Psychiatrists should be encouraged to continue utilizing lithium due to its proven effectiveness and life-saving potential.
Further research or educational initiatives may be needed to address the declining use of this vital medication.